Pharma Mar SA banner

Intrinsic Value

The intrinsic value of Pharma Mar SA (PMRA) under the Base Case is EUR per share. Compared with the current market price of 58.35 EUR, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

PMRA Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when PMRA is below its intrinsic value
Today Hidden ·
PMRA Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to PMRA

Fundamental Analysis

What Pharma Mar Does

Biotechnology Health Care

Pharma Mar is a Spanish biopharmaceutical company focused on cancer drugs. It discovers and develops medicines from marine organisms, then turns the best candidates into prescription treatments for hard-to-treat tumors. Its best-known products include oncology drugs sold directly or through partners in different markets.

Headquarters
Spain ES
Employees
505
IPO date
Nov 2, 2015
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue PMRA Research

Decided on Pharma Mar? Get an email when PMRA reaches the price you’d buy at. Free with an account.

Other Pharma Mar listings

What is the Intrinsic Value of one PMRA stock?

The intrinsic value for Pharma Mar SA (PMRA) under the Base Case is EUR.

Is PMRA stock undervalued or overvalued?

Compared with the current market price of 58.35 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top